Natco Pharma Ltd.

₹1011.6

Natco Pharma Ltd.

₹1011.6

₹1011.6

34.7 (3.55%) - 15 Jul 2025 04:24 PM

About Company

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The company manufactures API products which are primarily used for captive consumption in its FDF products and are also sold to customers for various international markets. In the API segment, company has capabilities to develop and manufacture products with multi-step synthesis, semi synthetic fusion technologies, high-potency APIs and peptides. It is also engaged in contract manufacturing business, whereby it undertakes selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products. It has diversified into the business of crop health sciences to leverage is skills in organic chemistry.

Market Cap. ₹ 18,119 Cr.
52 Week - High/Low ₹ 1,639/727
P/E Ratio 9.79
P/B Ratio 3.24
Enterprise Value ₹ 18,179 Cr.
ROE % 25.38
RSI Value 66.40
EMA 50 912.55
EMA 200 1014.43
Market Cap. ₹ 18,119 Cr.
52 Week - High/Low ₹ 1,639/727
P/E Ratio 9.60
P/B Ratio 3.10
Enterprise Value ₹ 18,074 Cr.
ROE % 25.88
RSI Value 66.40
EMA 50 912.55
EMA 200 1014.43

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.